Liver Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Women between 18 and 75 years of age
- People who have been diagnosed through a tissue/cell test (pathology) with breast cancer that has spread to the liver, and who are unable to have surgery or have chosen not to have surgery
- People who have no more than 3 liver tumours, with each individual tumour measuring 4cm or smaller
- People who have had at least 1 month pass since their last local treatment to the liver
- People whose liver function falls within a certain range, known as Child-Pugh class A or B (confirm with trial site)
- People who are well enough to carry out basic daily activities (rated on a standard scale), and whose life expectancy is greater than 3 months
Who may not be able to join:
- People whose liver function has declined to a severe level, known as Child-Pugh class C (confirm with trial site)
- People whose cancer has spread widely throughout the body with a life expectancy of less than 3 months
- People who have had bleeding from enlarged veins in the oesophagus or upper stomach within the past month
- People who have serious problems with how one or more of their major organs are working
- People who currently have an active infection
- People who have blood clotting problems that cannot be corrected
- People who have large amounts of fluid build-up in the abdomen or chest that has not responded to treatment, or who are in a state of severe physical decline (cachexia)
- People who are pregnant, have altered consciousness, or are unable to cooperate with the treatment process
- People who are currently still in the follow-up period of another clinical trial
- People who the trial doctor considers unsuitable for any other reason that might affect their participation
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Anti-tumor immune response
Can't join this trial?
Data last synced from ClinicalTrials.gov: 16 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.